Evidence map›Paper›PMID 18375383›Full record

ArticleThe Journal of biological chemistry2008

Interaction of HIV-1 gp41 core with NPF motif in Epsin: implication in endocytosis of HIV.

Jing-He Huang, Zhi Qi, Fan Wu, Leszek Kotula, Shibo Jiang, Ying-Hua Chen

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Jing-He HuangLaboratory of Immunology, Department of Biology, Tsinghua University, Protein Science Laboratory of the Ministry of Education, Beijing, China.
Zhi Qi
Fan Wu
Leszek Kotula
Shibo Jiang
Ying-Hua Chen
New York Blood Center · USTsinghua University · CNMassachusetts General Hospital · US

Funding

Rational Design of HIV Fusion Inhibitors Targeting gp41R01AI046221 · NIAID · NEW YORK BLOOD CENTER · PI JIANG, SHIBO · 2000 to 2010
$3.3M
NIAID NIH HHS R01 AI046221
6 · The paper itself

Abstract

The human immunodeficiency virus, type 1 (HIV-1), gp41 core plays an important role in fusion between viral and target cell membranes. We previously identified an HIV-1 gp41 core-binding motif HXXNPF (where X is any amino acid residue). In this study, we found that Asn, Pro, and Phe were the key residues for gp41 core binding. There are two NPF motifs in Epsin-1-(470-499), a fragment of Epsin, which is an essential accessory factor of endocytosis that can dock to the plasma membrane by interacting with the lipid. Epsin-1-(470-499) bound significantly to the gp41 core formed by the polypeptide N36(L8)C34 and interacted with the recombinant soluble gp41 containing the core structure. A synthetic peptide containing the Epsin-1-(470-499) sequence could effectively block entry of HIV-1 virions into SupT1 T cells via the endocytosis pathway. These results suggest that interaction between Epsin and the gp41 core, which may be present in the target cell membrane, is probably essential for endocytosis of HIV-1, an alternative pathway of HIV-1 entry into the target cell.

Indexed as

Adaptor Proteins, Vesicular TransportAmino Acid MotifsCell LineEndocytosisHIV-1HIV Envelope Protein gp41HumansMembrane LipidsPeptidesVirus InternalizationAdaptor Proteins, Vesicular Transportepsingp41 protein, Human immunodeficiency virus 1HIV Envelope Protein gp41Membrane LipidsPeptides

Identifiers

PMID18375383
PMCPMC2397473
OpenAlexW2058843177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.